5-carboxyamidotryptamine maleate
5-carboxyamidotryptamine maleate
5-carboxyamidotryptamine maleate 性质
| 储存条件 | -20°C |
|---|---|
| 溶解度 | H2O：可溶，10mg/mL |
| 形态 | 粉末 |
| 颜色 | 白色至类白色 |
| 水溶解性 | Soluble to 100 mM in water |
| InChI | 1S/C11H13N3O.C4H4O4/c12-4-3-8-6-14-10-2-1-7(11(13)15)5-9(8)10;5-3(6)1-2-4(7)8/h1-2,5-6,14H,3-4,12H2,(H2,13,15);1-2H,(H,5,6)(H,7,8)/b;2-1- |
| InChIKey | PZQZSWAOVAMBQM-BTJKTKAUSA-N |
| SMILES | OC(=O)\C=C/C(O)=O.NCCc1c[nH]c2ccc(cc12)C(N)=O |
5-carboxyamidotryptamine maleate 用途与合成方法
|
5-HT 1A Receptor
|
5-HT 1B Receptor
|
5-HT 1D Receptor
|
5-HT 5 Receptor
|
5-HT 7 Receptor
|
[
3
H]-5-Carboxamidotryptamine (5-CT) binding to 5-HT
1D
sites in bovine substantia nigra is rapid, reversible and saturable, displaying high affinity (K
d
= 0.38 nM) and low non-specific binding.
In bovine substantia nigra, [
3
H]-5-Carboxamidotryptamine (5-CT) labelled an equivalent number of binding sites to [
3
H]-5-Carboxamidotryptamine (403 and 362 fmol/mg protein, respectively) and binding is sensitive to guanine nucleotides.
Topical 5-Carboxamidotryptamine (0.01-1000 μM) to the exposed dura mater encephala produced decreases in diastolic blood pressure, variable changes in meningeal blood flow and increases in conductance (i.e. dilatation) in the middle meningeal artery of anesthetized Wistar rats (serotonin depletion and treated with 20 mg/kg corticosterone).
安全信息
| 危险品标志 | Xi |
|---|---|
| 危险类别码 | 36/37/38 |
| 安全说明 | 26-36 |
| WGK Germany | 3 |
| 存储类别 | 11 - 可燃固体 |
| 危险性类别 | 眼部刺激 类别2 经皮刺激 类别2 特异性靶器官毒性-一次接触，类别3 |
5-carboxyamidotryptamine maleate 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-09-15 | HY-100942 | 5-carboxyamidotryptamine maleate | 74885-72-6 | 1 mg | 285 |
| 2026-09-15 | HY-100942 | 5-carboxyamidotryptamine maleate | 74885-72-6 | 5 mg | 688 |
